MDV enters September with its borrow market still essentially frozen — and an earnings date on the calendar that gives the squeeze its next obvious flashpoint.
The lending picture has not materially changed since the previous note, but a subtle deterioration is worth flagging. Availability, which briefly touched 0.67% late last week, has tightened back to just 0.10% — meaning barely one share remains available for every thousand already borrowed. That near-zero condition has now held almost continuously since mid-August, with only fleeting windows where availability crept above 2% before collapsing again. Cost to borrow has eased very slightly to 13.8% annually, down about 1.6% on the week, but remains firmly in elevated territory — well above where it traded in early July when availability was in the 4–8% range and the borrow market had some room to breathe. Short interest itself remains deeply dug in at 20.7% of free float, and the ORTEX short score has ticked up again to 91.1 as of September 1, its highest reading in the current run. The overall message from the lending market is unchanged: shorts are locked in, new entrants cannot get in, and the financing cost for existing positions keeps grinding.
The Street picture is sparse — no recent analyst activity is available for this Warsaw-listed name, and historical target data is too stale to cite. What the factor scores do show is a deeply uncomfortable setup for bulls: MDV ranks in the bottom percentile of the ORTEX universe on both utilisation and availability, and the short score rank is zero out of one hundred. EPS momentum has been weak over 30 and 90 days. The valuation multiples offer a mixed read — a trailing P/E near 13.7x and EV/EBITDA around 5.9x are not stretched in isolation, but a price-to-book that has compressed roughly 5.5% over the past month and an earnings yield falling on a 30-day view suggest the market is not treating the current price as obviously cheap.
The most useful context for what comes next sits in the earnings history. The last major print, in early August, produced a one-day drop of 7.4% and a five-day follow-through loss of 6.6%. The June print before that went the other way, with a 0.3% day-one move and a 5% gain over the following week. The one before that was more explosive — an 11% one-day pop and nearly 25% over five days. MDV's earnings reactions are not consistent in direction, but they have been consistently large. With the next event scheduled for October 1 and the borrow market shut to new shorts, existing short holders have roughly four weeks in which the stock either confirms their thesis or does not — with no easy exit available at current borrow conditions.
Insider activity from July adds a minor counterpoint. Deputy Chairman Karol Poltorak bought 4,500 shares across three transactions at prices around PLN 102–103 in early July, a level now well above the current PLN 85.74 close. Those purchases represent modest sums in dollar terms but were made at prices roughly 20% above where the stock trades today — a gap that has widened as the stock has shed another 7.6% over the past month alone.
The October 1 earnings event is the next live variable: with availability near zero and short interest entrenched at 20.7% of float, the reaction to that print — in either direction — will be difficult for positioned investors to manage smoothly.
See the live data behind this article on ORTEX.
Open MDV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
